BioHarvest Sciences Inc. (BHST) delivered earnings and revenue surprises of +6.25% and -18.31%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
BioHarvest Sciences Inc. (BHST) delivered earnings and revenue surprises of +6.25% and -18.31%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
MiNK Therapeutics, Inc. (INKT) delivered earnings and revenue surprises of +24.24% and +33.33%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
ImmunityBio (IBRX) delivered earnings and revenue surprises of -25.00% and -19.60%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Wave Life Sciences (WVE) delivered earnings and revenue surprises of +11.77% and +342.29%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
BioHarvest Sciences Inc. (BHST) delivered earnings and revenue surprises of -30.77% and -10.51%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Celldex (CLDX) delivered earnings and revenue surprises of +9.62% and -98.75%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Arcus Biosciences (RCUS) delivered earnings and revenue surprises of +26.53% and +186.21%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Phathom Pharmaceuticals (PHAT) delivered earnings and revenue surprises of +100.00% and +1.71%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?